Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
Holekamp N, Gentile B, Giocanti-Aurégan A, García-Layana A, Peto T, Viola F, Kertes PJ, Mirt M, Kotecha A, Lambert J, Lewis HB, Chi GC. Holekamp N, et al. Among authors: garcia layana a. Ophthalmic Res. 2024;67(1):311-321. doi: 10.1159/000538975. Epub 2024 Apr 29. Ophthalmic Res. 2024. PMID: 38679018 Free article.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.
Izquierdo-Serra J, Martin-Pinardel R, Moll-Udina A, Bernal-Morales C, Garay-Aramburu G, Sanchez-Monroy J, Arruabarrena C, Fernandez-Hortelano A, Figueroa MS, Abraldes M, Lavid de Los Mozos FJ, Zapata MA, Ruiz-Moreno JM, Broc-Iturralde L, Gonzalez-Guijarro J, Escobar-Barranco JJ, Gallego-Pinazo R, Parrado-Carrillo A, Dotti-Boada M, Alforja S, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J; Writing Committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Izquierdo-Serra J, et al. Ophthalmol Retina. 2024 Apr;8(4):350-359. doi: 10.1016/j.oret.2023.10.022. Epub 2023 Nov 2. Ophthalmol Retina. 2024. PMID: 37924946
Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.
Saenz-de-Viteri M, Recalde S, Fernandez-Robredo P, López Gálvez MI, Arias Barquet L, Figueroa MS, García-Arumí J, García-Layana A; In-Eye Study Group. Saenz-de-Viteri M, et al. Acta Ophthalmol. 2021 Dec;99(8):861-870. doi: 10.1111/aos.14786. Epub 2021 Mar 15. Acta Ophthalmol. 2021. PMID: 33720541 Free article. Clinical Trial.
Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study.
Ruiz-Moreno JM, Adán A, Lafuente M, Asencio Durán M, Arias Barquet L, García Layana A, Araiz Iribarren J. Ruiz-Moreno JM, et al. Int Ophthalmol. 2023 Dec;43(12):4639-4649. doi: 10.1007/s10792-023-02864-2. Epub 2023 Sep 12. Int Ophthalmol. 2023. PMID: 37697082 Free PMC article.
Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021-2030): a societal perspective.
Pablo L, Garay-Aramburu G, García Layana A, Fernandez A, Vázquez I, Acebes X, Zulueta J, Balonga D, Salinas-Ortega L, Muñoz Á, Casado Gómez A, Casado MÁ, Salvador J, Bañón-Rodriguez I, Ruíz-Moreno JM. Pablo L, et al. Among authors: garcia layana a. Health Econ Rev. 2024 Sep 3;14(1):70. doi: 10.1186/s13561-024-00546-y. Health Econ Rev. 2024. PMID: 39225974 Free PMC article.
Conjunctival ultraviolet autofluorescence as a biomarker of outdoor time in myopic children.
de la Puente M, Bilbao-Malavé V, González-Zamora J, Claici AO, Bezunartea J, Gomez-Arteta L, Alonso E, Hernández M, Fernández-Robredo P, de Viteri MS, Calvo NM, García-Layana A, Barrio-Barrio J, Recalde S. de la Puente M, et al. Among authors: garcia layana a. Front Med (Lausanne). 2024 Dec 9;11:1492180. doi: 10.3389/fmed.2024.1492180. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39717180 Free PMC article.
Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study.
García-Layana A, Chi GC, Kodjikian L, Parravano M, Chow D, Jackson TL, Danzig C, Paris LP, Mirt M, Henry-Szatkowski M, Lewis HB, Gentile B. García-Layana A, et al. Ophthalmic Res. 2025;68(1):13-22. doi: 10.1159/000541349. Epub 2024 Nov 21. Ophthalmic Res. 2025. PMID: 39571557 Free article.
Caregiver Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration.
Viola F, Chi GC, Holekamp NM, Giocanti-Aurégan A, García-Layana A, Peto T, Kertes PJ, Mirt M, Kotecha A, Lambert J, Lewis HB, Gentile B. Viola F, et al. Among authors: garcia layana a. Ophthalmic Res. 2024;67(1):516-527. doi: 10.1159/000540390. Epub 2024 Aug 29. Ophthalmic Res. 2024. PMID: 39208778 Free article.
164 results